# A Trial of Grazax in Subjects With Hayfever

> **NCT00421655** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 329 (actual)

## Conditions studied

- Allergy

## Interventions

- **DRUG:** Grazax

## Key facts

- **NCT ID:** NCT00421655
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-10
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2015-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421655, "A Trial of Grazax in Subjects With Hayfever". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00421655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*